{
    "2025-03-27": [
        {
            "title": "Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update",
            "description": "Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 2025 Reviewing pipeline and development plans for HBV programsâ€¦",
            "source": "Financial Post",
            "url": "https://financialpost.com/globe-newswire/arbutus-reports-fourth-quarter-and-year-end-2024-financial-results-and-provides-corporate-update",
            "publishedAt": "2025-03-27T11:30:52Z"
        }
    ]
}